Rockefeller Capital Management’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-7,665
| Closed | -$447K | – | 1914 |
|
|
2023
Q1 | $447K | Buy |
7,665
+9
| +0.1% | +$525 | ﹤0.01% | 1401 |
|
|
2022
Q4 | $475K | Hold |
7,656
| – | – | ﹤0.01% | 1308 |
|
|
2022
Q3 | $432K | Sell |
7,656
-15
| -0.2% | -$846 | ﹤0.01% | 1332 |
|
|
2022
Q2 | $490K | Buy |
7,671
+3
| +0% | +$192 | ﹤0.01% | 1267 |
|
|
2022
Q1 | $496K | Buy |
7,668
+15
| +0.2% | +$970 | ﹤0.01% | 1317 |
|
|
2021
Q4 | $509K | Sell |
7,653
-816
| -10% | -$54.3K | ﹤0.01% | 1303 |
|
|
2021
Q3 | $517K | Sell |
8,469
-96
| -1% | -$5.86K | ﹤0.01% | 1244 |
|
|
2021
Q2 | $530K | Buy |
8,565
+2,217
| +35% | +$137K | ﹤0.01% | 1173 |
|
|
2021
Q1 | $375K | Buy |
6,348
+39
| +0.6% | +$2.3K | ﹤0.01% | 1120 |
|
|
2020
Q4 | $377K | Buy |
6,309
+6
| +0.1% | +$359 | ﹤0.01% | 1003 |
|
|
2020
Q3 | $343K | Buy |
+6,303
| New | +$343K | ﹤0.01% | 904 |
|